+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "ACE Inhibitor"

From
From
From
From
From
From
From
Diabetic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
Myocardial Infarction - Pipeline Insight, 2024 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
Cardiovascular Calcification - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiovascular Calcification - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Myocarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Myocarditis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator

The ACE Inhibitor market is a segment of the pharmaceutical industry that focuses on drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. ACE inhibitors are a type of medication that works by blocking the action of an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a hormone called angiotensin II, which can cause blood vessels to narrow and increase blood pressure. By blocking the action of ACE, ACE inhibitors can help reduce blood pressure and improve the symptoms of heart failure. ACE inhibitors are typically prescribed in combination with other medications, such as diuretics, beta-blockers, and calcium channel blockers. They are also used to treat other conditions, such as kidney disease, diabetes, and migraines. Some companies in the ACE Inhibitor market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more